Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera
Authors
Keywords
-
Journal
LEUKEMIA
Volume 26, Issue 4, Pages 563-571
Publisher
Springer Nature
Online
2011-11-11
DOI
10.1038/leu.2011.314
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
- (2011) F. Passamonti et al. BLOOD
- Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies
- (2011) R. V. Tiu et al. BLOOD
- Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet
- (2011) Tiziano Barbui et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment-Related Risk Factors for Transformation to Acute Myeloid Leukemia and Myelodysplastic Syndromes in Myeloproliferative Neoplasms
- (2011) Magnus Björkholm et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloproliferative Neoplasms: Molecular Pathophysiology, Essential Clinical Understanding, and Treatment Strategies
- (2011) Ayalew Tefferi et al. JOURNAL OF CLINICAL ONCOLOGY
- Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis
- (2011) M. CARRIER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond
- (2011) Alfonso Quintás-Cardama et al. NATURE REVIEWS DRUG DISCOVERY
- Apixaban in Patients with Atrial Fibrillation
- (2011) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heparin-Induced Thrombocytopenia in Patients with Philadelphia-Negative Myeloproliferative Disorders and Unusual Splanchnic or Cerebral Vein Thrombosis
- (2010) Maria L. Randi et al. ACTA HAEMATOLOGICA
- Is the JAK2 V617F Mutation a Hallmark for Different Forms of Thrombosis
- (2010) Katja Zerjavic et al. ACTA HAEMATOLOGICA
- JAK2Mutations Across a Spectrum of Venous Thrombosis Cases: Table 1
- (2010) Shrimati Shetty et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia
- (2010) A. Alvarez-Larran et al. BLOOD
- Thromboprophylactic management in the neurosurgical patient with high risk for both thrombosis and intracranial bleeding
- (2010) Tomi Niemi et al. Current Opinion in Anesthesiology
- Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
- (2010) T. Barbui et al. HAEMATOLOGICA
- Molecular aspects of myeloproliferative neoplasms
- (2010) François Delhommeau et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
- (2010) A Tefferi et al. LEUKEMIA
- Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
- (2010) A Tefferi LEUKEMIA
- A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications
- (2010) F Passamonti et al. LEUKEMIA
- New antithrombotic agents—insights from clinical trials
- (2010) Jeremy S. Paikin et al. Nature Reviews Cardiology
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Rivaroxaban for Symptomatic Venous Thromboembolism
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis
- (2010) Sebastien Richard et al. PLATELETS
- High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis
- (2010) Vittorio Rosti et al. PLoS One
- Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms
- (2010) Jérôme Duchemin et al. THROMBOSIS RESEARCH
- Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation
- (2009) Valerio De Stefano et al. ANNALS OF HEMATOLOGY
- Mechanisms of mutations in myeloproliferative neoplasms
- (2009) Ross L. Levine BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
- (2009) S. Sozer et al. BLOOD
- Prevention of venous thromboembolism in the orthopedic surgery patient.
- (2009) S. B Deitelzweig et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- JAK2V617F Mutation in Patients with Splanchnic Vein Thrombosis
- (2009) Sandra Guerra Xavier et al. DIGESTIVE DISEASES AND SCIENCES
- JAK2V617F allele burden and thrombosis: A direct comparison in essential thrombocythemia and polycythemia vera
- (2009) Alessandra Carobbio et al. EXPERIMENTAL HEMATOLOGY
- Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera
- (2009) Alfonso Quintás-Cardama et al. JOURNAL OF CLINICAL ONCOLOGY
- JAK2V617F Mutation-positive Childhood Essential Thrombocythemia Associated With Cerebral Venous Sinus Thrombosis
- (2009) Hidemitsu Kurosawa et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Aspirin, 110 years later
- (2009) C. PATRONO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
- (2009) A Tefferi et al. LEUKEMIA
- JAK2V617F Mutation Screening as Part of the Hypercoagulable Work-up in the Absence of Splanchnic Venous Thrombosis or Overt Myeloproliferative Neoplasm: Assessment of Value in a Series of 664 Consecutive Patients
- (2009) Animesh Pardanani et al. MAYO CLINIC PROCEEDINGS
- A Randomized Trial of Rosuvastatin in the Prevention of Venous Thromboembolism
- (2009) Robert J. Glynn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
- (2009) Sam Schulman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism
- (2009) D. Green Hematology-American Society of Hematology Education Program
- Pregnancy-associated thrombosis
- (2009) A. H. James Hematology-American Society of Hematology Education Program
- Heparin-induced thrombocytopenia in myeloproliferative disorders: A rare or under-diagnosed complication?
- (2008) Galia Spectre et al. AMERICAN JOURNAL OF HEMATOLOGY
- Complications of Splenectomy
- (2008) Ali Cadili et al. AMERICAN JOURNAL OF MEDICINE
- Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia
- (2008) A. M. Vannucchi et al. BLOOD
- Pegylated interferon-alfa-2a induces complete hematologic and molecular responses with low toxicity in polycythemia vera
- (2008) J.-J. Kiladjian et al. BLOOD
- The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases
- (2008) J.-J. Kiladjian et al. BLOOD
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Virchow and his triad: a question of attribution
- (2008) Catherine N. Bagot et al. BRITISH JOURNAL OF HAEMATOLOGY
- Prevalence of theJAK2V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms
- (2008) Tommaso Za et al. BRITISH JOURNAL OF HAEMATOLOGY
- Anagrelide: 20 years later
- (2008) Ashkan Emadi et al. Expert Review of Anticancer Therapy
- Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments
- (2008) V. De Stefano et al. HAEMATOLOGICA
- Prevention of thrombosis in polycythemia vera and essential thrombocythemia
- (2008) R. Landolfi et al. HAEMATOLOGICA
- Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia
- (2008) E. Antonioli et al. HAEMATOLOGICA
- Massive Intraventricular Thrombus in Polycythemia Vera
- (2008) Shi-Min Yuan et al. JOURNAL OF CARDIAC SURGERY
- Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms
- (2008) J-J Kiladjian et al. LEUKEMIA
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey
- (2007) M. Ruggeri et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now